Winkler CK, Tasnádi G, Clay D, Hall M, Faber K. Asymmetric bioreduction of activated alkenes to industrially relevant optically active compounds.
J Biotechnol 2012;
162:381-9. [PMID:
22498437 PMCID:
PMC3521962 DOI:
10.1016/j.jbiotec.2012.03.023]
[Citation(s) in RCA: 110] [Impact Index Per Article: 9.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2011] [Revised: 03/23/2012] [Accepted: 03/28/2012] [Indexed: 12/01/2022]
Abstract
Ene-reductases from the ‘Old Yellow Enzyme’ family of flavoproteins catalyze the asymmetric reduction of various α,β-unsaturated compounds at the expense of a nicotinamide cofactor. They have been applied to the synthesis of valuable enantiopure products, including chiral building blocks with broad industrial applications, terpenoids, amino acid derivatives and fragrances. The combination of these highly stereoselective biocatalysts with a cofactor recycling system has allowed the development of cost-effective methods for the generation of optically active molecules, which is strengthened by the availability of stereo-complementary enzyme homologues.
Collapse